Phase 1A Safety Trial of Inhaled PK10571 (GB002)
Clinical trial NCT03473236 · COMPLETED
Trial details
- NCT number
- NCT03473236
- Sponsor
- GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-06
- Primary completion
- 2018-12-03
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.